Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp V.TMD


Primary Symbol: T.TMD

Healthcare Medical Devices
Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Conavi Medical Corp
Bullboard Posts
User Avatar Image
(15)
•••
Post by bayoubuckson Feb 04, 2016 2:56pm
220 Views
Post# 24525276

U.S. Trading

U.S. TradingTrading in the U.S.

O .75
H 1.11
L .75
LAST .76
VOL 767,503

Down .27 from yesterdays close.  11/04/15 all over again. Big run up in price then an equity financing announcement.  See for yourself if you don't believe me. 
My real concern is that the sp goes up mysteriously then the company does an equity financing.  Sound suspcious or am I just being paranoid? Wonder if the regulators have noticed this.  I hope not.
Not surprisingly, I haven't received a response from Hargrove to my eamail wherein I asked him how come the Nov financing was supposed to be to build 5 units and now the latest financing NR says the purpose is to only build 3. Have they misjudged the cost that much or what other reason could it be?  I'm not bashing, sitting here with over 100k warrants, but I think we need an explanation from management as to what's going on.  Am I p'od, darn right!!!  And you should be too. 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities